{"transactions":[{"id":1615186,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-02-27T17:02:52.000Z","date":"2024-02-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units are settled in common stock upon vesting, which occurred on February 23, 2024."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3886},"source":{"system":"sec-edgar","filing":"0001104659-24-028277","document":"tm247055-19_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465924028277/tm247055-19_4seq1.xml","form_type":"4"}},{"id":1615185,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-27T17:02:52.000Z","date":"2024-02-23","kind":"grant","planned":false,"acquired":true,"shares":3886,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":87943,"source":{"system":"sec-edgar","filing":"0001104659-24-028277","document":"tm247055-19_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465924028277/tm247055-19_4seq1.xml","form_type":"4"}},{"id":1618959,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-26T17:01:53.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":5369,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 22, 2025."}],"balance_after":5369,"derivative":{"underlying":"Common Stock","underlying_shares":5369},"source":{"system":"sec-edgar","filing":"0001104659-24-027576","document":"tm247055-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465924027576/tm247055-10_4seq1.xml","form_type":"4"}},{"id":1618958,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2024-02-26T17:01:53.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":8252,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on February 22, 2025."}],"balance_after":8252,"derivative":{"exercise_price":27.94,"expiration_date":"2034-02-22","underlying":"Common Stock","underlying_shares":8252},"source":{"system":"sec-edgar","filing":"0001104659-24-027576","document":"tm247055-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465924027576/tm247055-10_4seq1.xml","form_type":"4"}},{"id":1989932,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-27T17:01:09.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":3886,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 23, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"These restricted stock units will be settled in common stock upon vesting, which will occur on February 23, 2024."}],"balance_after":3886,"derivative":{"underlying":"Common Stock","underlying_shares":3886},"source":{"system":"sec-edgar","filing":"0001104659-23-026073","document":"tm237737-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465923026073/tm237737-12_4seq1.xml","form_type":"4"}},{"id":1989931,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2023-02-27T17:01:09.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":6293,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on February 23, 2024."}],"balance_after":6293,"derivative":{"exercise_price":38.6,"expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":6293},"source":{"system":"sec-edgar","filing":"0001104659-23-026073","document":"tm237737-12_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465923026073/tm237737-12_4seq1.xml","form_type":"4"}},{"id":1992693,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-24T17:16:48.000Z","date":"2023-02-22","kind":"disposition_to_issuer","acquired":false,"shares":3882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 22, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3882},"source":{"system":"sec-edgar","filing":"0001104659-23-025383","document":"tm237737-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465923025383/tm237737-5_4seq1.xml","form_type":"4"}},{"id":1992692,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-24T17:16:48.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":3882,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":84057,"source":{"system":"sec-edgar","filing":"0001104659-23-025383","document":"tm237737-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465923025383/tm237737-5_4seq1.xml","form_type":"4"}},{"id":2374356,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-24T21:26:11.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":3882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units will be settled in common stock upon vesting, such vesting to occur on February 22, 2023."}],"balance_after":3882,"derivative":{"underlying":"Common Stock","underlying_shares":3882},"source":{"system":"sec-edgar","filing":"0001104659-22-026880","document":"tm227622-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465922026880/tm227622-6_4seq1.xml","form_type":"4"}},{"id":2374355,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2022-02-24T21:26:11.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":6847,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6847,"derivative":{"exercise_price":32.2,"exercise_date":"2023-02-22","expiration_date":"2032-02-22","underlying":"Common Stock","underlying_shares":6847},"source":{"system":"sec-edgar","filing":"0001104659-22-026880","document":"tm227622-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465922026880/tm227622-6_4seq1.xml","form_type":"4"}},{"id":2377893,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-23T16:15:04.000Z","date":"2022-02-19","kind":"disposition_to_issuer","acquired":false,"shares":4222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These restricted stock units were settled in common stock upon vesting, which occurred on February 19, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4222},"source":{"system":"sec-edgar","filing":"0001104659-22-026096","document":"tm227492-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465922026096/tm227492-1_4seq1.xml","form_type":"4"}},{"id":2377892,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-02-23T16:15:04.000Z","date":"2022-02-19","kind":"grant","acquired":true,"shares":4222,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":80175,"source":{"system":"sec-edgar","filing":"0001104659-22-026096","document":"tm227492-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465922026096/tm227492-1_4seq1.xml","form_type":"4"}},{"id":2605203,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-08-12T16:32:56.000Z","date":"2021-08-11","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":12.98,"exercise_date":"2017-03-01","expiration_date":"2026-03-01","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-21-104206","document":"tm2124999-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465921104206/tm2124999-1_4seq1.xml","form_type":"4"}},{"id":2605202,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-08-12T16:32:56.000Z","date":"2021-08-11","kind":"exercise","acquired":true,"shares":15000,"price":12.98,"value":194700.0,"ownership":{"direct":true},"balance_after":75953,"source":{"system":"sec-edgar","filing":"0001104659-21-104206","document":"tm2124999-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465921104206/tm2124999-1_4seq1.xml","form_type":"4"}},{"id":2838737,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-02-23T18:49:23.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":4222,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These shares will be settled in common stock upon vesting, such vesting to occur on February 19, 2022."}],"balance_after":4222,"derivative":{"underlying":"Common Stock","underlying_shares":4222},"source":{"system":"sec-edgar","filing":"0001104659-21-026930","document":"tm217706-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465921026930/tm217706-5_4seq1.xml","form_type":"4"}},{"id":2838736,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-02-23T18:49:23.000Z","date":"2021-02-19","kind":"grant","acquired":true,"shares":7365,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7365,"derivative":{"exercise_price":29.61,"exercise_date":"2022-02-19","expiration_date":"2031-02-19","underlying":"Common Stock","underlying_shares":7365},"source":{"system":"sec-edgar","filing":"0001104659-21-026930","document":"tm217706-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465921026930/tm217706-5_4seq1.xml","form_type":"4"}},{"id":3248741,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2020-02-25T17:24:32.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":9305,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9305,"derivative":{"exercise_price":23.99,"exercise_date":"2021-02-21","expiration_date":"2030-02-21","underlying":"Common Stock","underlying_shares":9305},"source":{"system":"sec-edgar","filing":"0001104659-20-024846","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465920024846/a4.xml","form_type":"4"}},{"id":3248740,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-02-25T17:24:32.000Z","date":"2020-02-21","kind":"grant","acquired":true,"shares":5211,"price":23.99,"value":125011.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit component of the annual equity compensation to directors.  These shares will be settled in common stock upon vesting, such vesting to occur on February 21, 2021.  Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting."}],"balance_after":60953,"source":{"system":"sec-edgar","filing":"0001104659-20-024846","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465920024846/a4.xml","form_type":"4"}},{"id":3479886,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-06-24T20:06:26.000Z","date":"2019-06-20","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.13,"exercise_date":"2016-03-03","expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-19-037264","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465919037264/a4.xml","form_type":"4"}},{"id":3479885,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-24T20:06:26.000Z","date":"2019-06-20","kind":"exercise","acquired":true,"shares":10000,"price":9.13,"value":91300.0,"ownership":{"direct":true},"balance_after":55742,"source":{"system":"sec-edgar","filing":"0001104659-19-037264","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465919037264/a4.xml","form_type":"4"}},{"id":3546530,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-04-29T15:43:54.000Z","date":"2019-04-25","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10000,"derivative":{"exercise_price":9.13,"exercise_date":"2016-03-03","expiration_date":"2025-03-03","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001104659-19-024504","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465919024504/a4.xml","form_type":"4"}},{"id":3546529,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-29T15:43:54.000Z","date":"2019-04-25","kind":"exercise","acquired":true,"shares":10000,"price":9.13,"value":91300.0,"ownership":{"direct":true},"balance_after":45742,"source":{"system":"sec-edgar","filing":"0001104659-19-024504","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465919024504/a4.xml","form_type":"4"}},{"id":3618344,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-03-04T17:52:56.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":12427,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12427,"derivative":{"exercise_price":36.75,"exercise_date":"2020-02-22","expiration_date":"2029-02-22","underlying":"Common Stock","underlying_shares":12427},"source":{"system":"sec-edgar","filing":"0001104659-19-012549","document":"a4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465919012549/a4a.xml","form_type":"4/A","original_submission_date":"2019-02-26"}},{"id":3618342,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-03-04T17:41:41.000Z","date":"2018-08-20","kind":"exercise","acquired":false,"shares":7457,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":9.24,"exercise_date":"2015-01-21","expiration_date":"2024-01-21","underlying":"Common Stock","underlying_shares":7457},"source":{"system":"sec-edgar","filing":"0001104659-19-012547","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465919012547/a4.xml","form_type":"4"}},{"id":3618341,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-03-04T17:41:41.000Z","date":"2018-08-20","kind":"exercise","acquired":false,"shares":8722,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":7.9,"exercise_date":"2014-02-05","expiration_date":"2023-02-05","underlying":"Common Stock","underlying_shares":8722},"source":{"system":"sec-edgar","filing":"0001104659-19-012547","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465919012547/a4.xml","form_type":"4"}},{"id":3618340,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-04T17:41:41.000Z","date":"2018-08-20","kind":"exercise","acquired":true,"shares":7457,"price":9.24,"value":68902.68,"ownership":{"direct":true},"balance_after":35742,"source":{"system":"sec-edgar","filing":"0001104659-19-012547","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465919012547/a4.xml","form_type":"4"}},{"id":3618339,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-04T17:41:41.000Z","date":"2018-08-20","kind":"exercise","acquired":true,"shares":8722,"price":7.9,"value":68903.8,"ownership":{"direct":true},"balance_after":28285,"source":{"system":"sec-edgar","filing":"0001104659-19-012547","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465919012547/a4.xml","form_type":"4"}},{"id":3631539,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-02-26T19:24:31.000Z","date":"2019-02-22","kind":"grant","acquired":true,"shares":12427,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12427,"derivative":{"exercise_price":36.75,"exercise_date":"2020-02-22","expiration_date":"2029-02-22","underlying":"Common Stock","underlying_shares":12427},"source":{"system":"sec-edgar","filing":"0001104659-19-010794","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465919010794/a4.xml","form_type":"4"}},{"id":3983350,"issuer":{"id":155143,"kind":"organization","name":"ARADIGM CORP","symbol":"ARDM"},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim Principal Exec Ofcr"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-03-26T20:28:30.000Z","date":"2018-03-22","kind":"grant","acquired":true,"shares":276000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option vests (a) as to 96,000 shares on August 12, 2018 and (b) as to 180,000 shares in 36 equal monthly installments over a three-year period beginning on March 12, 2018."}],"balance_after":276000,"derivative":{"exercise_price":1.31,"expiration_date":"2028-03-22","underlying":"Common Stock","underlying_shares":276000},"source":{"system":"sec-edgar","filing":"0001123292-18-000559","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013238/000112329218000559/edgar.xml","form_type":"4"}},{"id":4029768,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2018-02-27T17:46:06.000Z","date":"2018-02-23","kind":"grant","acquired":true,"shares":8613,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":8613,"derivative":{"exercise_price":39.4,"exercise_date":"2019-02-23","expiration_date":"2028-02-23","underlying":"Common Stock","underlying_shares":8613},"source":{"system":"sec-edgar","filing":"0001104659-18-012893","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465918012893/a4.xml","form_type":"4"}},{"id":4280478,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-06-15T16:43:21.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":6036,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6036,"derivative":{"exercise_price":38.6,"exercise_date":"2018-06-13","expiration_date":"2027-06-13","underlying":"Common Stock","underlying_shares":6036},"source":{"system":"sec-edgar","filing":"0001104659-17-039594","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465917039594/a4.xml","form_type":"4"}},{"id":4293832,"issuer":{"id":155143,"kind":"organization","name":"ARADIGM CORP","symbol":"ARDM"},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-05T17:55:03.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":110485,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest and become exercisable in four equal quarterly installments over one year beginning on June 1, 2017, subject to such individual continuing to be a Participant (as defined in the 2015 Equity Incentive Plan) on the relevant vesting dates."}],"balance_after":110485,"derivative":{"exercise_price":1.39,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":110485},"source":{"system":"sec-edgar","filing":"0001123292-17-001083","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1013238/000112329217001083/edgar.xml","form_type":"4"}},{"id":4420996,"issuer":{"id":4333,"kind":"organization","name":"SUPERNUS PHARMACEUTICALS, INC."},"owners":[{"id":93806,"kind":"person","name":"SIEBERT JOHN M","position":1,"cik":"0001190558","reported_name":"SIEBERT JOHN M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2017-02-27T21:56:25.000Z","date":"2017-02-24","kind":"grant","acquired":true,"shares":7905,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":7905,"derivative":{"exercise_price":25.3,"exercise_date":"2018-02-24","expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":7905},"source":{"system":"sec-edgar","filing":"0001104659-17-012171","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1190558/000110465917012171/a4.xml","form_type":"4"}}]}